Molecular logic of mTORC1 signalling as a metabolic rheostat
- PMID: 32694720
- DOI: 10.1038/s42255-019-0038-7
Molecular logic of mTORC1 signalling as a metabolic rheostat
Abstract
The protein kinase complex mechanistic target of rapamycin complex 1 (mTORC1) serves as a key conduit between growth signals and the metabolic processes underlying cell growth. The activation state of mTORC1 is controlled by intracellular nutrients and energy, as well as exogenous hormones and growth factors, thereby integrating local and systemic growth signals. Here we discuss the molecular logic of the mTORC1 signalling network and its importance in coupling growth signals to the control of cellular metabolism. After activation, mTORC1 promotes the conversion of available nutrients and energy into the major macromolecular species contributing to cellular mass, including proteins, nucleic acids and lipids, while suppressing the autophagic recycling of these macromolecules back into their nutrient constituents. Given that uncoupling of mTORC1 from its normal regulatory inputs contributes to many diseases-including cancer, genetic tumour syndromes, metabolic diseases, autoimmune diseases and neurological disorders-understanding the molecular logic of the mTORC1 network and how to modulate it may present therapeutic opportunities for treatment of a broad range of diseases and potentially even for the extension of lifespan.
References
-
- Singh, K., Sun, S. & Vézina, C. Rapamycin (AY-22,989), a new antifungal antibiotic. IV. Mechanism of action. J. Antibiot. (Tokyo) 32, 630–645 (1979). - DOI
-
- Düvel, K. et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 39, 171–183 (2010). This study defines a set of transcripts encoding metabolic enzymes that are sensitive to mTORC1 activation and inhibition. Transcriptional profiling and metabolomics reveal that mTORC1 induces glycolysis, the oxidative pentose-phosphate pathway and de novo lipid synthesis through activation of the HIF1 and SREBP transcription factors. - PubMed - PMC - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
